Top 5 Zacks #1 Ranked Healthcare Mutual Funds - Best of Funds
2012年11月23日 - 9:35PM
Zacks
The healthcare sector is one of the most desirable avenues for
parking investments when markets are headed south. The demand for
such services usually remains unchanged even during an economic
downturn and investments in the sector provide sufficient
protection to the capital invested. Several pharmaceutical
companies also provide regular dividends, which can boost current
income for investors. Healthcare mutual funds provide the perfect
avenue for investors looking to invest in this sector.
Below we will share with you 5 top rated healthcare mutual
funds. Each has earned a Zacks #1 Rank (Strong Buy) as we expect
these mutual funds to outperform their peers in the future.
To view the Zacks Rank and past performance of all health funds,
investors can click here to see the complete list of funds.
Fidelity Select Biotechnology (FBIOX) invests a majority
of its assets in common stocks of companies which are primarily
involved in research and development as well as production and
distribution of products from the biotechnology space of the
healthcare sector. It focuses on domestic as well as foreign
securities. The healthcare mutual fund has a one year annualized
return of 61.09%.
Rajiv Kaul is the fund manager and has managed this healthcare
mutual fund since 2005.
Rydex Biotechnology (RYOIX) seeks capital growth by
investing predominantly in equity shares issued by domestic
biotechnology companies. It primarily focuses on small and mid-cap
companies. The fund also invests in derivative products. The
healthcare mutual fund has a one year annualized return of 56.41%.
< p> As of October 2012, this healthcare mutual fund held 46
issues, with 9.98% of its total assets invested in Amgen Inc.
Franklin Biotechnology Discovery A (FBDIX) invests the
majority of its assets in equity shares of biotechnology companies
and research entities. The fund may also invest some of its assets
in non-biotechnology companies. The healthcare mutual fund has a
one year annualized return of 54.02%.
The healthcare mutual fund has a minimum initial investment of $
1,000 and an expense ratio of 1.26% compared to a category average
of 1.52%.
VALIC Company I Health Sciences (VCHSX) seeks capital
appreciation by investing a majority of its assets in common stocks
of companies from the healthcare sector with a primary focus on
large and mid-cap companies. The healthcare mutual fund has a one
year annualized return of 48.01%.
Kris H. Jenner is the fund manager and has managed this
healthcare mutual fund since 2000.
T. Rowe Price Health Sciences (PRHSX) invests the
majority of its assets in common stocks of companies from the
healthcare sector. The fund focuses on investing in large and
mid-cap firms. It may also invest in foreign securities. The
healthcare mutual fund has a one year annualized return of
47.93%.
The healthcare mutual fund has a minimum initial investment of $
2,500 and an expense ratio of 0.82% compared to a category average
of 1.52%.
To view the Zacks Rank and past performance of all health mutual
funds, investors can click here to see the complete list of
funds.
About Zacks Mutual Fund Rank
By applying the Zacks Rank to mutual funds, investors can find
funds that not only outpaced the market in the past but are also
expected to outperform going forward. Learn more about the Zacks
Mutual Fund Rank at http://www.zacks.com/funds.
View All Zacks #1 Ranked Mutual Funds
(FBDIX): ETF Research Reports
(FBIOX): ETF Research Reports
(PRHSX): ETF Research Reports
(RYOIX): ETF Research Reports
(VCHSX): ETF Research Reports
To read this article on Zacks.com click here.
Zacks Investment Research